Senior Regional Marketer, Neurology (West Region)

The role

The Senior Regional Marketer serves as a strategic connection between thought leaders, regional markets, and the organization. This person will develop relationships with neurology community leaders and translate marketplace insights into commercial strategies.

What you will do

• Serve as a commercial liaison to neurology thought leaders.
• Develop and execute strategic thought leader engagement plans.
• Maintain thought leader mapping and engagement strategies.
• Engage thought leaders at congresses, professional meetings, and advocacy events.
• Gather and synthesize insights to inform brand strategy and educational needs.
• Facilitate engagement between thought leaders and Axsome leadership.
• Communicate emerging customer needs and market trends to brand teams.
• Support the development, training, and support of promotional speakers.
• Plan and execute commercial advisory boards.
• Partner with cross-functional colleagues in Marketing, Sales, Medical, and more.

Required qualifications

• Bachelor’s degree
• 8+ years of pharmaceutical, biotechnology, or relevant healthcare industry experience
• At least 2 years of relevant cross-functional experience across two or more areas such as Regional or HCP Marketing, Thought Leader/KOL Engagement, Product or Brand Marketing, Field Sales, Field Sales
• Demonstrated experience developing relationships with thought leaders/KOLs and other influential healthcare stakeholders
• Ability and willingness to travel approximately 50–75%, including air and automobile travel

Nice to have

• Advanced degree
• Experience in regional marketing, brand/product marketing, sales leadership, or pharmaceutical product launches
• Neurology, neuroscience, or other CNS experience

Benefits

• Annual bonus
• Significant equity
• Generous benefits package

About the company

Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. Their neuroscience portfolio includes FDA-approved treatments for major depressive disorder, agitation associated with dementia due to Alzheimer’s disease, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine.